Akston Biosciences Corporation (AXTN)
Akston Biosciences will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
2,222,222
Deal Size
$20.00M
Akston Biosciences Revenue
Akston Biosciences had revenue of $6.97M in the twelve months ending June 30, 2025. In the year 2024, Akston Biosciences had annual revenue of $16.49M with 222.32% growth.
Revenue (ttm)
$6.97M
Revenue Growth
+222.32%
P/S Ratio
9.76
Revenue / Employee
$107,203
Employees
65
Market Cap
67.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.49M | 11.37M | 222.32% |
| Dec 31, 2023 | 5.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAXTN News
- 3 days ago - Akston Biosciences IPO Registration Document (S-1) - SEC
- 3 days ago - Pet biotech Akston Biosciences files and sets terms for a $20 million IPO - Renaissance Capital